SOPHARMA AD - Annual Consolidated Audited Financial report for 2018 of Sopharma Group

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 10 / 2019

Date of issue: 2019-04-25

Short name of the issuer

SOPHARMA AD

Subject

Annual Consolidated Audited Financial report for 2018 of Sopharma Group

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sopharma Group Financial report according to IFRS as at 31 December 2018 consolidated Sopharma Group Notes to the financial report as at 31 December 2018 consolidated Sopharma Group Management report as at 31 December 2018 consolidated Sopharma Group Financial report according to BFCS standards as at 31 December 2018 consolidated Sopharma Group Declaration as at 31 December 2018 consolidated Sopharma Group Auditor's report as at 31 December 2018 consolidated Sopharma Group Auditor's declaration as at 31 December 2018 consolidated Sopharma Group Corporate governance report as at 31 December 2018 consolidated Sopharma Group Nonfinancial declaration as at 31 December 2018 consolidated Sopharma Group List of insider information as at 31 December 2018 consolidated Sopharma Group Financial report according to IFRS in Excel as at 31 December 2018 consolidated

Annexes

File Description

3JR_Annual_audited_consolidated_FS_2018_EN.rar Annual Consolidated Audited Financial report for 2018 of Sopharma Group

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2019-04-25 Ognian Donev Executive director